AlzChem Group AG (ETR:ACT)

AlzChem Group AG Balance Sheet

Financials in millions EUR. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	69.35	71.72	61.54	11.88	9.24	8.29
Short-Term Investments	-	-	0	-	5.23	0
Cash & Short-Term Investments	69.35	71.72	61.54	11.88	14.47	8.29
Cash Growth	-24.11%	16.54%	417.92%	-17.88%	74.67%	-51.60%
Accounts Receivable	86.28	73.42	78.94	75.21	55.71	40.84
Other Receivables	37.45	35.52	20.15	22.01	19.74	16.78
Total Trade Receivables	123.73	108.94	99.09	97.22	75.46	57.62
Inventory	122.58	116	101.17	107.48	122.4	86.68
Other Current Assets	-	-	-	-	2.31	-
Total Current Assets	315.65	296.66	261.8	216.58	214.64	152.58
Net Property, Plant & Equipment	301.56	279.97	197	182.14	187.78	186.49
Other Intangible Assets	3.85	3.53	3.67	3.66	2.95	2.33
Long-Term Investments	0.01	0.01	0.01	0.01	0.01	0.02
Other Long-Term Assets	33.41	37.51	21.36	22.29	17.49	36.24
Total Assets	654.48	617.68	483.83	424.68	422.86	377.67

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	74.54	51.73	37.43	31.55	37.39	32.78
Accrued Expenses	4.49	7.19	3.41	3.54	1.94	2.97
Short-Term Debt	-	0	1.99	0	-	0
Current Portion of Long-Term Debt	6.34	6.37	7.59	8.83	66.41	10.49
Current Portion of Leases	1.84	1.87	1.83	1.61	1.71	1.81
Unearned Revenue	4.66	2.43	0	-	-	0
Other Current Liabilities	47.58	49.31	53.15	37.09	24.66	28.08
Total Current Liabilities	139.45	118.9	105.4	82.63	132.11	76.13
Long-Term Debt	33.17	34.75	41.08	48.67	27.5	37.55
Long-Term Leases	0.84	1.24	2.33	3.38	4.62	5.79
Other Long-Term Liabilities	204.96	204.56	127.55	126.45	112.69	168.63
Total Long-Term Liabilities	238.97	240.54	170.96	178.49	144.81	211.98
Total Liabilities	378.41	359.45	276.36	261.12	276.91	288.1

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	101.76	101.76	101.76	101.76	101.76	101.76
Treasury Stock	-5.41	-4.11	-1.51	0	-1.01	-1.01
Additional Paid-in Capital	-61.07	-61.07	-63.48	-63.48	-62.47	-63.15
Accumulated Other Comprehensive Income	-11.27	-12.4	-18.08	-21.64	-15.32	-51.1
Retained Earnings	250.07	232.11	186.84	144.98	121.04	101.13
Total Common Shareholders' Equity	274.09	258.23	205.54	163.56	145.95	87.63
Minority Interest	1.98	1.93	1.93	1.93	1.93	1.93
Shareholders' Equity	276.06	260.17	207.47	165.49	147.88	89.56
Total Liabilities & Equity	654.48	617.68	483.83	424.68	422.86	377.67

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	42.19	44.23	54.82	62.49	100.24	55.64
Net Cash (Debt)	27.16	27.49	6.73	-50.61	-85.76	-47.36
Net Cash Growth	-34.08%	308.64%	-	-	-	-
Net Cash Per Share	2.69	2.72	0.66	-4.98	-8.46	-4.67
Book Value	274.09	258.23	205.54	163.56	145.95	87.63
Book Value Per Share	27.11	25.55	20.20	16.08	14.40	8.64
Tangible Book Value	270.24	254.7	201.87	159.9	142.99	85.3
Tangible Book Value Per Share	26.73	25.20	19.84	15.72	14.11	8.41

Data Source: Fiscal.ai Last updated: Apr 30, 2026

Financial data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 27, 2026

Data Sources Report a data error